Vox Markets Interview with Avacta CEO Alastair Smith

0 विचारों· 09/19/23
The Vox Markets Podcast
The Vox Markets Podcast
0 ग्राहकों
0
में

Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.

और दिखाओ

 0 टिप्पणियाँ sort   इसके अनुसार क्रमबद्ध करें


अगला